^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

burixafor (GPC-100)

i
Associations
Company:
GPCR Therap, TaiGen
Drug class:
CXCR4 antagonist
Associations
Phase 2
GPCR Therapeutics, Inc.
Completed
Last update posted :
05/11/2021
Initiation :
02/01/2010
Primary completion :
10/01/2011
Completion :
10/01/2011
CD34
|
burixafor (GPC-100)
Phase 2
GPCR Therapeutics, Inc.
Completed
Last update posted :
04/19/2021
Initiation :
02/01/2015
Primary completion :
11/01/2015
Completion :
11/01/2015
CD34
|
burixafor (GPC-100)
Phase 2
GPCR Therapeutics, Inc.
Completed
Last update posted :
04/19/2021
Initiation :
10/01/2012
Primary completion :
07/01/2013
Completion :
07/01/2013
CD34
|
burixafor (GPC-100)